Francis Y Yao, MD
Gastroenterology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 4 carriers
- Offices
- 7
Offices
7 locations · UCSF Dept of Surgery · Regents of the University of California · UCSF Medical Group Business Services · County of Santa Clara
Looking this up.
Hospitals listed: John Muir Medical Center - Walnut Creek Campus · Marinhealth Medical Center · Mills-Peninsula Medical Center · Santa Clara Valley Medical Center · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
21 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yao’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G65786 · Current
Licensed to practise in California · since 1989 · expires 2028-09-30 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$98,546
Medicare paid this office $98,546 for 326 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 205 | $47,927 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $16,418 | $105 |
| Long return visit (40+ min) | 35 | $9,946 | $163 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 195 | $5,116 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,912 | $153 |
See all 9 services
| Long return visit (40+ min) | 205 | $47,927 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $16,418 | $105 |
| Long return visit (40+ min) | 35 | $9,946 | $163 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 195 | $5,116 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,912 | $153 |
| New patient visit (60+ min) | 22 | $3,158 | $144 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 37 | $830 | $15 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $604 | $25 |
| Measurement of liver stiffness | 14 | $132 | $9 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
326 Original Medicare patients in 2024. Average age 71 · Under 65 14% · 85 and older 7% · Women 48% · Also on Medicaid 40% · Health risk score 2.00. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 41% · Chronic kidney disease 32% · Coronary heart disease 25% · Depression 19% · Cancer 16% · Atrial fibrillation 16% · Heart failure 13% · COPD 11% · Stroke 9% · Dementia 5%.
The office billed $634,781, Medicare allowed $129,017 and paid $98,546; for 1,238 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 326 | 1,238 | 71 | 2.00 | $634,781 | $98,546 |
| 2023 | 325 | 864 | 71 | 2.14 | $610,481 | $93,713 |
| 2022 | 296 | 785 | 71 | 2.17 | $570,543 | $87,694 |
| 2021 | 317 | 801 | 70 | 1.90 | $565,949 | $88,648 |
| 2020 | 288 | 765 | 69 | 2.12 | $538,273 | $77,611 |
| 2019 | 298 | 706 | 70 | 2.35 | $511,882 | $69,827 |
| 2018 | 336 | 724 | 69 | 2.09 | $520,874 | $72,606 |
| 2017 | 292 | 635 | 68 | 2.08 | $460,524 | $63,837 |
| 2016 | 296 | 688 | 68 | 2.14 | $456,210 | $66,499 |
| 2015 | 283 | 692 | 68 | 2.23 | $475,962 | $68,085 |
| 2014 | 268 | 641 | 66 | 2.19 | $433,406 | $61,976 |
| 2013 | 233 | 527 | 67 | 2.18 | $323,508 | $47,346 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 203 | $47,415 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $17,387 | $107 |
| Long return visit (40+ min) | 35 | $9,578 | $162 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,163 | $156 |
| New patient visit (60+ min) | 24 | $3,290 | $137 |
| Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 12 | $1,326 | $28 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $908 | $28 |
| Measurement of liver stiffness | 15 | $134 | $9 |
2022: 9 services
| Long return visit (40+ min) | 184 | $44,738 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $14,858 | $91 |
| Long return visit (40+ min) | 32 | $7,742 | $161 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,752 | $176 |
| New patient visit (60+ min) | 24 | $3,694 | $154 |
| Extended patient service without direct patient contact, first hour | 28 | $2,660 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,200 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $784 | $49 |
| Measurement of liver stiffness | 13 | $125 | $10 |
2021: 10 services
| Long return visit (40+ min) | 181 | $41,255 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $14,959 | $92 |
| Long return visit (40+ min) | 25 | $6,669 | $163 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,906 | $179 |
| New patient visit (60+ min) | 35 | $5,784 | $165 |
| Return visit (30+ min) | 26 | $2,743 | $83 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 25 | $1,450 | $29 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,351 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,284 | $64 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $670 | $61 |
2020: 10 services
| Long return visit (40+ min) | 156 | $27,875 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $20,480 | $96 |
| Long return visit (40+ min) | 30 | $6,673 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,375 | $179 |
| Extended patient service without direct patient contact, first hour | 39 | $3,955 | $101 |
| New patient visit (60+ min) | 23 | $3,494 | $152 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $2,003 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,260 | $66 |
| Return visit (30+ min) | 18 | $1,217 | $61 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,131 | $103 |
2019: 8 services
| Long return visit (40+ min) | 153 | $23,960 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $15,658 | $93 |
| Long return visit (40+ min) | 35 | $7,107 | $132 |
| New patient visit (60+ min) | 32 | $4,818 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,848 | $65 |
| Extended patient service without direct patient contact, first hour | 28 | $2,817 | $101 |
| Return visit (30+ min) | 34 | $2,748 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,540 | $181 |
2018: 7 services
| Long return visit (40+ min) | 164 | $23,760 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $17,180 | $92 |
| Long return visit (40+ min) | 41 | $7,547 | $126 |
| New patient visit (60+ min) | 41 | $5,934 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $5,006 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,328 | $65 |
| Return visit (30+ min) | 19 | $1,830 | $65 |
2017: 7 services
| Long return visit (40+ min) | 143 | $21,819 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $14,220 | $92 |
| Long return visit (40+ min) | 34 | $6,442 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,219 | $180 |
| New patient visit (60+ min) | 36 | $5,215 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,003 | $65 |
| Return visit (30+ min) | 21 | $1,500 | $52 |
2016: 7 services
| Long return visit (40+ min) | 156 | $21,610 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $19,596 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,682 | $178 |
| New patient visit (60+ min) | 32 | $4,513 | $141 |
| Long return visit (40+ min) | 23 | $4,297 | $126 |
| Return visit (30+ min) | 32 | $2,600 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,665 | $67 |
2015: 6 services
| Long return visit (40+ min) | 161 | $26,898 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $15,548 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $6,171 | $181 |
| New patient visit (60+ min) | 32 | $4,538 | $142 |
| Return visit (30+ min) | 44 | $3,537 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,476 | $65 |
2014: 6 services
| Long return visit (40+ min) | 145 | $24,277 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $14,146 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $6,143 | $181 |
| Return visit (30+ min) | 61 | $4,876 | $59 |
| New patient visit (60+ min) | 27 | $3,927 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,093 | $61 |
2013: 7 services
| Long return visit (40+ min) | 110 | $15,662 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $9,178 | $90 |
| Return visit (30+ min) | 82 | $6,424 | $59 |
| New patient visit (60+ min) | 19 | $2,759 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,695 | $168 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,653 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $944 | $63 |
Medicaid work
$51,998 in 2024
Medicaid paid $51,998 for 541 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 364 | $28,438 |
| Long return visit (40+ min) | 177 | $23,560 |
| 2024 | 541 | 2 | 28 | $51,998 |
| 2023 | 448 | 3 | 28 | $42,394 |
| 2022 | 339 | 2 | 22 | $31,771 |
| 2021 | 364 | 2 | 25 | $31,979 |
| 2020 | 258 | 4 | 24 | $18,592 |
| 2019 | 70 | 2 | 18 | $3,602 |
| 2018 | 107 | 2 | 21 | $6,230 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 270 | $21,077 |
| Long return visit (40+ min) | 163 | $19,207 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $2,110 |
2022
| Long return visit (40+ min) | 151 | $18,190 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 188 | $13,581 |
2021
| Long return visit (40+ min) | 184 | $19,982 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 180 | $11,997 |
2020
| Long return visit (40+ min) | 153 | $12,410 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 79 | $5,484 |
| Telehealth originating site facility fee | 13 | $586 |
| Telehealth transmission, per minute, professional services bill separately | 13 | $112 |
2019
| Long return visit (40+ min) | 35 | $2,036 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $1,566 |
2018
| Long return visit (40+ min) | 95 | $6,230 |
| Hospital outpatient clinic visit for assessment and management of a patient | 12 | $0 |
Drugs they prescribed that Part D paid
$1,369,263
Pharmacies billed $1,369,263 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
977 generic and 616 brand-name prescriptions · $1,369,263 in drug cost · 105 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 501 | $944,526 | $1,885 |
| Xifaxan | 66 | $214,072 | $3,244 |
| Entecavir | 227 | $54,932 | $242 |
| Baraclude | 22 | $48,002 | $2,182 |
| Ursodiol | 101 | $20,529 | $203 |
See all 21 drugs
| Vemlidy | 501 | $944,526 | $1,885 |
| Xifaxan | 66 | $214,072 | $3,244 |
| Entecavir | 227 | $54,932 | $242 |
| Baraclude | 22 | $48,002 | $2,182 |
| Ursodiol | 101 | $20,529 | $203 |
| Tenofovir Disoproxil | 35 | $5,250 | $150 |
| Azathioprine | 63 | $2,456 | $39 |
| Lactulose | 40 | $1,522 | $38 |
| Pantoprazole | 39 | $691 | $18 |
| Atorvastatin | 49 | $601 | $12 |
| Mercaptopurine | 11 | $533 | $48 |
| Omeprazole | 47 | $430 | $9 |
| Spironolactone | 24 | $342 | $14 |
| Allopurinol | 17 | $310 | $18 |
| Prednisone | 58 | $299 | $5 |
| Ciprofloxacin | 17 | $291 | $17 |
| Propranolol | 21 | $217 | $10 |
| Gavilyte-G | 12 | $195 | $16 |
| Mirtazapine | 18 | $55 | $3 |
| Furosemide | 15 | $29 | $2 |
| Trazodone | 11 | $29 | $3 |
Year by year
| 2024 | 1,593 | 230 | None | 39% | $1,369,263 |
| 2023 | 1,567 | 220 | 0% (0) | None | $1,616,348 |
| 2022 | 1,280 | 197 | 0% (0) | None | $1,111,600 |
| 2021 | 1,352 | 200 | None | 43% | $1,026,003 |
| 2020 | 1,236 | 181 | None | None | $948,717 |
| 2019 | 1,220 | 177 | 0% (0) | 34% | $784,359 |
| 2018 | 1,326 | 161 | 0% (0) | None | $868,523 |
| 2017 | 1,248 | 160 | 0% (0) | None | $858,247 |
| 2016 | 1,269 | 164 | None | None | $952,027 |
| 2015 | 1,285 | 153 | 0% (0) | None | $812,209 |
| 2014 | 1,080 | 130 | None | None | $640,365 |
| 2013 | 789 | 113 | None | 54% | $520,022 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Vemlidy | 609 | $1,047,106 | $1,719 |
| Xifaxan | 61 | $210,842 | $3,456 |
| Entecavir | 193 | $95,116 | $493 |
| Baraclude | 23 | $61,223 | $2,662 |
| Ursodiol | 104 | $26,398 | $254 |
| Tenofovir Disoproxil | 31 | $9,415 | $304 |
| Azathioprine | 50 | $2,925 | $59 |
| Lactulose | 29 | $2,486 | $86 |
| Omeprazole | 47 | $1,049 | $22 |
| Atorvastatin | 53 | $1,037 | $20 |
| Spironolactone | 24 | $1,025 | $43 |
| Constulose | 14 | $812 | $58 |
| Pantoprazole | 19 | $596 | $31 |
| Ciprofloxacin | 30 | $536 | $18 |
| Prednisone | 60 | $372 | $6 |
| Propranolol | 13 | $329 | $25 |
| Allopurinol | 13 | $303 | $23 |
| Gavilyte-G | 13 | $240 | $18 |
| Furosemide | 22 | $187 | $9 |
2022: 17 drugs
| Vemlidy | 489 | $780,794 | $1,597 |
| Xifaxan | 43 | $137,878 | $3,206 |
| Entecavir | 201 | $59,041 | $294 |
| Ursodiol | 120 | $37,799 | $315 |
| Baraclude | 18 | $34,074 | $1,893 |
| Esomeprazole Magnesium | 15 | $3,198 | $213 |
| Lactulose | 23 | $2,072 | $90 |
| Azathioprine | 26 | $1,846 | $71 |
| Tenofovir Disoproxil | 16 | $1,210 | $76 |
| Spironolactone | 27 | $1,099 | $41 |
| Omeprazole | 39 | $588 | $15 |
| Atorvastatin | 36 | $462 | $13 |
| Propranolol | 13 | $415 | $32 |
| Pantoprazole | 17 | $313 | $18 |
| Ciprofloxacin | 22 | $219 | $10 |
| Prednisone | 25 | $163 | $7 |
| Allopurinol | 15 | $136 | $9 |
2021: 17 drugs
| Vemlidy | 454 | $633,447 | $1,395 |
| Xifaxan | 58 | $177,786 | $3,065 |
| Entecavir | 226 | $48,700 | $215 |
| Baraclude | 15 | $32,727 | $2,182 |
| Ursodiol | 111 | $32,499 | $293 |
| Tenofovir Disoproxil | 37 | $2,429 | $66 |
| Azathioprine | 22 | $1,272 | $58 |
| Lactulose | 30 | $1,243 | $41 |
| Spironolactone | 24 | $818 | $34 |
| Pantoprazole | 27 | $693 | $26 |
| Omeprazole | 53 | $668 | $13 |
| Atorvastatin | 44 | $552 | $13 |
| Propranolol | 21 | $548 | $26 |
| Ciprofloxacin | 24 | $500 | $21 |
| Simvastatin | 18 | $144 | $8 |
| Allopurinol | 15 | $132 | $9 |
| Prednisone | 17 | $132 | $8 |
2020: 18 drugs
| Vemlidy | 367 | $538,395 | $1,467 |
| Xifaxan | 61 | $179,929 | $2,950 |
| Ocaliva | 13 | $87,733 | $6,749 |
| Entecavir | 238 | $50,624 | $213 |
| Ursodiol | 91 | $33,719 | $371 |
| Tenofovir Disoproxil | 58 | $4,545 | $78 |
| Azathioprine | 18 | $1,827 | $101 |
| Lactulose | 34 | $1,314 | $39 |
| Ciprofloxacin | 35 | $961 | $27 |
| Spironolactone | 24 | $849 | $35 |
| Pantoprazole | 25 | $748 | $30 |
| Atorvastatin | 36 | $509 | $14 |
| Omeprazole | 36 | $442 | $12 |
| Propranolol | 12 | $387 | $32 |
| Levothyroxine | 12 | $231 | $19 |
| Furosemide | 21 | $158 | $8 |
| Prednisone | 13 | $114 | $9 |
| Famotidine | 11 | $104 | $9 |
2019: 17 drugs
| Vemlidy | 263 | $337,738 | $1,284 |
| Xifaxan | 54 | $147,093 | $2,724 |
| Entecavir | 270 | $107,988 | $400 |
| Ocaliva | 14 | $86,806 | $6,200 |
| Baraclude | 13 | $35,108 | $2,701 |
| Ursodiol | 88 | $32,429 | $369 |
| Tenofovir Disoproxil | 66 | $6,915 | $105 |
| Azathioprine | 13 | $1,146 | $88 |
| Lactulose | 26 | $1,072 | $41 |
| Spironolactone | 50 | $847 | $17 |
| Atorvastatin | 38 | $753 | $20 |
| Ciprofloxacin | 56 | $704 | $13 |
| Omeprazole | 26 | $549 | $21 |
| Pantoprazole | 18 | $453 | $25 |
| Prednisone | 27 | $171 | $6 |
| Gabapentin | 13 | $111 | $9 |
| Furosemide | 22 | $109 | $5 |
2018: 24 drugs
| Entecavir | 316 | $249,596 | $790 |
| Vemlidy | 176 | $236,078 | $1,341 |
| Xifaxan | 52 | $120,725 | $2,322 |
| Ocaliva | 12 | $80,559 | $6,713 |
| Viread | 29 | $33,136 | $1,143 |
| Baraclude | 17 | $32,127 | $1,890 |
| Truvada | 18 | $29,899 | $1,661 |
| Ursodiol | 101 | $29,742 | $294 |
| Tenofovir Disoproxil | 67 | $26,085 | $389 |
| Mercaptopurine | 11 | $1,765 | $160 |
| Azathioprine | 23 | $1,590 | $69 |
| Spironolactone | 66 | $1,200 | $18 |
| Lactulose | 18 | $1,003 | $56 |
| Mycophenolate Mofetil | 12 | $965 | $80 |
| Ciprofloxacin | 36 | $831 | $23 |
| Pantoprazole | 30 | $817 | $27 |
| Atorvastatin | 36 | $686 | $19 |
| Propranolol | 20 | $448 | $22 |
| Omeprazole | 51 | $414 | $8 |
| Prednisone | 21 | $197 | $9 |
| Furosemide | 26 | $141 | $5 |
| Levothyroxine | 12 | $119 | $10 |
| Gabapentin | 17 | $85 | $5 |
| Simvastatin | 14 | $25 | $2 |
2017: 19 drugs
| Viread | 198 | $252,642 | $1,276 |
| Entecavir | 292 | $232,337 | $796 |
| Xifaxan | 57 | $136,045 | $2,387 |
| Baraclude | 27 | $64,117 | $2,375 |
| Vemlidy | 44 | $58,993 | $1,341 |
| Truvada | 23 | $36,329 | $1,580 |
| Ursodiol | 69 | $22,921 | $332 |
| Azathioprine | 30 | $2,251 | $75 |
| Lactulose | 25 | $1,503 | $60 |
| Pantoprazole | 47 | $766 | $16 |
| Omeprazole | 58 | $765 | $13 |
| Spironolactone | 37 | $553 | $15 |
| Atorvastatin | 35 | $435 | $12 |
| Propranolol Hcl Er | 11 | $405 | $37 |
| Propranolol | 16 | $367 | $23 |
| Ciprofloxacin | 21 | $346 | $16 |
| Furosemide | 40 | $188 | $5 |
| Famotidine | 14 | $128 | $9 |
| Gavilyte-G | 11 | $113 | $10 |
2016: 21 drugs
| Viread | 198 | $245,742 | $1,241 |
| Entecavir | 273 | $241,772 | $886 |
| Xifaxan | 62 | $120,204 | $1,939 |
| Baraclude | 52 | $112,954 | $2,172 |
| Truvada | 28 | $40,581 | $1,449 |
| Ursodiol | 101 | $36,133 | $358 |
| Lactulose | 51 | $3,130 | $61 |
| Spironolactone | 44 | $1,151 | $26 |
| Pantoprazole | 58 | $919 | $16 |
| Ciprofloxacin | 44 | $604 | $14 |
| Azathioprine | 14 | $586 | $42 |
| Propranolol | 13 | $585 | $45 |
| Omeprazole | 54 | $494 | $9 |
| Atorvastatin | 20 | $397 | $20 |
| Ondansetron | 12 | $235 | $20 |
| Furosemide | 36 | $209 | $6 |
| Famotidine | 12 | $118 | $10 |
| Pravastatin | 11 | $46 | $4 |
| Metformin | 11 | $42 | $4 |
| Sulfamethoxazole-Trimethoprim | 13 | $34 | $3 |
| Citalopram Hbr | 12 | $19 | $2 |
2015: 19 drugs
| Baraclude | 128 | $214,633 | $1,677 |
| Xifaxan | 98 | $166,468 | $1,699 |
| Viread | 134 | $158,747 | $1,185 |
| Entecavir | 165 | $155,855 | $945 |
| Ursodiol | 91 | $34,823 | $383 |
| Truvada | 16 | $28,408 | $1,775 |
| Lactulose | 59 | $3,513 | $60 |
| Spironolactone | 55 | $1,329 | $24 |
| Pantoprazole | 104 | $1,255 | $12 |
| Generlac | 20 | $810 | $41 |
| Ciprofloxacin | 54 | $687 | $13 |
| Azathioprine | 24 | $667 | $28 |
| Propranolol | 25 | $619 | $25 |
| Omeprazole | 33 | $433 | $13 |
| Atorvastatin | 17 | $339 | $20 |
| Furosemide | 49 | $218 | $4 |
| Sulfamethoxazole-Trimethoprim | 32 | $175 | $5 |
| Famotidine | 15 | $102 | $7 |
| Citalopram Hbr | 12 | $40 | $3 |
2014: 22 drugs
| Baraclude | 163 | $258,358 | $1,585 |
| Viread | 125 | $143,090 | $1,145 |
| Xifaxan | 77 | $111,510 | $1,448 |
| Entecavir | 38 | $44,684 | $1,176 |
| Truvada | 21 | $35,927 | $1,711 |
| Ursodiol | 50 | $7,498 | $150 |
| Nexium | 13 | $4,263 | $328 |
| Spironolactone | 49 | $1,048 | $21 |
| Lactulose | 23 | $1,024 | $45 |
| Pantoprazole | 86 | $927 | $11 |
| Atorvastatin | 32 | $620 | $19 |
| Omeprazole | 48 | $530 | $11 |
| Ciprofloxacin | 39 | $370 | $9 |
| Azathioprine | 12 | $319 | $27 |
| Propranolol | 38 | $244 | $6 |
| Sulfamethoxazole-Trimethoprim | 30 | $190 | $6 |
| Ondansetron | 12 | $156 | $13 |
| Triamterene-Hydrochlorothiazid | 11 | $133 | $12 |
| Furosemide | 45 | $123 | $3 |
| Famotidine | 15 | $114 | $8 |
| Hydrochlorothiazide | 12 | $86 | $7 |
| Citalopram Hbr | 13 | $48 | $4 |
2013: 17 drugs
| Baraclude | 144 | $186,219 | $1,293 |
| Viread | 117 | $112,887 | $965 |
| Xifaxan | 66 | $87,653 | $1,328 |
| Truvada | 15 | $18,896 | $1,260 |
| Nexium | 20 | $9,260 | $463 |
| Epivir Hbv | 16 | $8,262 | $516 |
| Lactulose | 20 | $1,702 | $85 |
| Atorvastatin | 23 | $1,075 | $47 |
| Ursodiol | 16 | $853 | $53 |
| Omeprazole | 45 | $656 | $15 |
| Pantoprazole | 50 | $612 | $12 |
| Spironolactone | 15 | $374 | $25 |
| Propranolol | 32 | $310 | $10 |
| Ciprofloxacin | 21 | $205 | $10 |
| Famotidine | 12 | $91 | $8 |
| Hydrochlorothiazide | 14 | $84 | $6 |
| Furosemide | 12 | $39 | $3 |
Money from drug and device companies
$25,136 in 2025
| 2025 | 2 | 21 | $20,158 | $25,136 |
| 2024 | 3 | 31 | $30,620 | $36,223 |
| 2023 | 1 | 15 | $12,200 | $15,400 |
| 2022 | 1 | 16 | $11,140 | $14,559 |
| 2021 | 1 | 10 | $11,340 | $12,783 |
| 2020 | 3 | 13 | $11,480 | $13,386 |
| 2019 | 3 | 46 | $32,850 | $41,232 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Vemlidy | $12,980 | 11 payments
|
| Boston Scientific | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) | $12,156 | 10 payments
|
See all 21 published payments
| Boston Scientific | Paid to speak or teach · 2025-12-18 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) | $1,875 |
| Boston Scientific | Paid to speak or teach · 2025-12-18 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) | $5,938 |
| Boston Scientific | Paid to speak or teach · 2025-12-18 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) | $1,000 |
| Boston Scientific | Travel · 2025-12-18 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) | $886 |
| Boston Scientific | Meals · 2025-11-15 | Therasphere Y90 Glass Microspheres 10 Gbq | $398 |
| Boston Scientific | Travel · 2025-11-14 | Therasphere Y90 Glass Microspheres 10 Gbq | $292 |
| Boston Scientific | Meals · 2025-11-14 | Therasphere Y90 Glass Microspheres 10 Gbq | $695 |
| Boston Scientific | Meals · 2025-11-13 | Therasphere Y90 Glass Microspheres 10 Gbq | $154 |
| Boston Scientific | Travel · 2025-11-13 | Therasphere Y90 Glass Microspheres 10 Gbq | $292 |
| Gilead Sciences | Meals · 2025-11-08 | Livdelzi | $103 |
| Gilead Sciences | Consulting · 2025-10-15 | Vemlidy | $1,630 |
| Gilead Sciences | Paid to speak or teach · 2025-09-23 | Vemlidy | $3,030 |
| Gilead Sciences | Travel · 2025-09-16 | Vemlidy | $701 |
| Gilead Sciences | Meals · 2025-09-12 | Vemlidy | $109 |
| Gilead Sciences | Travel · 2025-06-02 | Vemlidy | $555 |
| Gilead Sciences | Paid to speak or teach · 2025-05-30 | Vemlidy | $3,030 |
| Gilead Sciences | Meals · 2025-05-29 | Vemlidy | $130 |
| Gilead Sciences | Travel · 2025-05-12 | None | $613 |
| Gilead Sciences | Paid to speak or teach · 2025-05-08 | None | $3,030 |
| Gilead Sciences | Meals · 2025-05-07 | None | $49 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) | $625 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $36,223
| Gilead Sciences | Vemlidy | $20,794 | 22 payments
|
| Boston Scientific | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) | $15,292 | 8 payments
|
| Mallinckrodt Hospital Products | Terlivaz | $137 | 1 payment
|
2023: $15,400
| Gilead Sciences | Vemlidy | $15,400 | 15 payments
|
2022: $14,559
| Gilead Sciences | Vemlidy | $14,559 | 16 payments
|
2021: $12,783
| Gilead Sciences | Vemlidy | $12,783 | 10 payments
|
2020: $13,386
| Gilead Sciences | Vemlidy | $10,871 | 11 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $2,500 | 1 payment
|
| Medtronic USA | Kyphon Balloon Kyphoplasty | $15 | 1 payment
|
2019: $41,232
| Gilead Sciences | Vemlidy | $38,386 | 42 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $2,752 | 3 payments
|
| Biocompatibles | Therasphere-Bio | $94 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 82.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134177470
- Licence
- CA G65786California G65786: Current · expires 2028-09-30
- Group
- UCSF Dept of Surgery · Regents of the University of California · UCSF Medical Group Business Services · County of Santa Clara
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 0G6578600
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 1635 Divisadero Street, Suite 625, Box 1821, San Francisco, CA, 94143
- NPI first listed
- 2006-05-05
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.